Effect of Pharmacist-Led Intervention in Elderly Patients through a Comprehensive Medication Reconciliation: A Randomized Clinical Trial

다국어 초록 (Multilingual Abstract)

Purpose: Polypharmacy can cause drug-related problems, such as potentially inappropriate medication (PIM) use and med ication regimen complexity in the elderly. This study aimed to investigate the feasibility and effectiveness of a collaborative medication review and comprehensive medication reconciliation intervention by a pharmacist and hospitalist for older pa tients.
Materials and Methods: This comprehensive medication reconciliation study was designed as a prospective, open-label, ran domized clinical trial with patients aged 65 years or older from July to December 2020. Comprehensive medication reconcilia tion comprised medication reviews based on the PIM criteria. The discharge of medication was simplified to reduce regimen complexity. The primary outcome was the difference in adverse drug events (ADEs) throughout hospitalization and 30 days after discharge. Changes in regimen complexity were evaluated using the Korean version of the medication regimen complex ity index (MRCI-K).
Results: Of the 32 patients, 34.4% (n=11/32) reported ADEs before discharge, and 19.2% (n=5/26) ADEs were reported at the 30-day phone call. No ADEs were reported in the intervention group, whereas five events were reported in the control group (p=0.039) on the 30-day phone call. The mean acceptance rate of medication reconciliation was 83%. The mean decreases of MRCI-K be tween at the admission and the discharge were 6.2 vs. 2.4, although it was not significant (p=0.159).
Conclusion: As a result, we identified the effect of pharmacist-led interventions using comprehensive medication reconciliation, including the criteria of the PIMs and the MRCI-K, and the differences in ADEs between the intervention and control groups at the 30-day follow-up after discharge in elderly patients.
Trial Registration: (Clinical trial number: KCT0005994)

참고문헌 (Reference)

1 Masnoon N, "What is polypharmacy? A systematic review of definitions" 17 : 230-, 2017

2 Earl TR, "Using deprescribing practices and the screening tool of older persons'potentially inappropriate prescriptions criteria to reduce harm and preventable adverse drug events in older adults" 16 (16): S23-S35, 2020

3 McNab D, "Systematic review and meta-analysis of the effectiveness of pharmacist-led medication reconciliation in the community after hospital discharge" 27 : 308-320, 2018

4 O’Mahony D, "STOPP/START criteria for potentially inappropriate prescribing in older people : version 2" 44 : 213-218, 2015

5 Schnipper JL, "Role of pharmacist counseling in preventing adverse drug events after hospitalization" 166 : 565-571, 2006

6 Jetha S, "Polypharmacy, the elderly, and deprescribing" 30 : 527-532, 2015

7 Mekonnen AB, "Pharmacy-led medication reconciliation programmes at hospital transitions : a systematic review and meta-analysis" 41 : 128-144, 2016

8 Fernandes BD, "Pharmacist-led medication reconciliation at patient discharge : a scoping review" 16 : 605-613, 2020

9 Gustafsson M, "Pharmacist participation in hospital ward teams and hospital readmission rates among people with dementia : a randomized controlled trial" 73 : 827-835, 2017

10 Daliri S, "Medication-related interventions delivered both in hospital and following discharge : a systematic review and meta-analysis" 30 : 146-156, 2021

11 Dautzenberg L, "Medication review interventions to reduce hospital readmissions in older people" 69 : 1646-1658, 2021

12 Willson MN, "Medication regimen complexity and hospital readmission for an adverse drug event" 48 : 26-32, 2014

13 Patel CH, "Medication complexity, medication number, and their relationships to medication discrepancies" 50 : 534-540, 2016

14 Tang JY, "Intervention elements and behavior change techniques to improve prescribing for older adults with multimorbidity in Singapore : a modified Delphi study" 13 : 531-539, 2022

15 Johansen JS, "Interdisciplinary collaboration across secondary and primary care to improve medication safety in the elderly(IMMENSE study) : study protocol for a randomised controlled trial" 8 : e020106-, 2018

16 Nachtigall A, "Influence of pharmacist intervention on drug safety of geriatric inpatients : a prospective, controlled trial" 10 : 2042098619843365-, 2019

17 Morello CM, "Improved glycemic control with minimal change in medication regimen complexity in a pharmacist-endocrinologist diabetes intense medical management(DIMM)"tune up"clinic" 52 : 1091-1097, 2018

18 Phatak A, "Impact of pharmacist involvement in the transitional care of high-risk patients through medication reconciliation, medication education, and postdischarge call-backs(IPITCH study)" 11 : 39-44, 2016

19 Sluggett JK, "Impact of medication regimen simplification on medication administration times and health outcomes in residential aged care : 12 month follow up of the SIMPLER randomized controlled trial" 9 : 1053-, 2020

20 Al-Hashar A, "Impact of medication reconciliation and review and counselling, on adverse drug events and healthcare resource use" 40 : 1154-1164, 2018

21 Leguelinel-Blache G, "Impact of collaborative pharmaceutical care on inpatients’medication safety : study protocol for a stepped wedge cluster randomized trial(MEDREV study)" 19 : 19-, 2018

22 Elliott RA, "Impact of an intervention to reduce medication regimen complexity for older hospital inpatients" 35 : 217-224, 2013

23 Mueller SK, "Hospitalbased medication reconciliation practices : a systematic review" 172 : 1057-1069, 2012

24 Gillespie U, "Effects of pharmacists’ interventions on appropriateness of prescribing and evaluation of the instruments’(MAI, STOPP and STARTs’)ability to predict hospitalization--analyses from a randomized controlled trial" 8 : e62401-, 2013

25 Lenander C, "Effects of a pharmacist-led structured medication review in primary care on drug-related problems and hospital admission rates : a randomized controlled trial" 32 : 180-186, 2014

26 Spinewine A, "Effect of a collaborative approach on the quality of prescribing for geriatric inpatients : a randomized, controlled trial" 55 : 658-665, 2007

27 Lee S, "Development and validation of the Korean version of the medication regimen complexity index" 14 : e0216805-, 2019

28 Van der Linden L, "Clinical pharmacy services in older inpatients : an evidencebased review" 37 : 161-174, 2020

29 Wimmer BC, "Clinical outcomes associated with medication regimen complexity in older people : a systematic review" 65 : 747-753, 2017

30 Weir DL, "Both new and chronic potentially inappropriate medications continued at hospital discharge are associated with increased risk of adverse events" 68 : 1184-1192, 2020

31 2019 American Geriatrics Society Beers Criteria® Update Expert Panel, "American Geriatrics Society 2019 updated AGS Beers Criteria ® for potentially inappropriate medication use in older ddults" 67 : 674-694, 2019

32 Hyttinen V, "A systematic review of the impact of potentially inappropriate medication on health care utilization and costs among older adults" 54 : 950-964, 2016

33 Hanlon JT, "A randomized, controlled trial of a clinical pharmacist intervention to improve inappropriate prescribing in elderly outpatients with polypharmacy" 100 : 428-437, 1996

34 Gillespie U, "A comprehensive pharmacist intervention to reduce morbidity in patients 80 years or older : a randomized controlled trial" 169 : 894-900, 2009